We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · February 02, 2020

Real-World Use and Survival Outcomes of Immune Checkpoint Inhibitors in Older Adults With NSCLC

Cancer

 

Additional Info

Disclosure statements are available on the authors' profiles:

Cancer
Real-World Use and Survival Outcomes of Immune Checkpoint Inhibitors in Older Adults With Non-Small Cell Lung Cancer
Cancer 2020 Jan 14;[EPub Ahead of Print], B Youn, NA Trikalinos, V Mor, IB Wilson, IJ Dahabreh

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading